10x Genomics, Inc. (TXG)
$61.53-$3.32 (-5.12%) Today
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 18 | 125,496 | $6.74M |
| Grant or award | 6 | 52,974 | |
| Bona-fide gift | 1 | 4,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
42 Form 4 filings on record, the earliest from Nov 18, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 3,500 | $63.02 | $221K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 6,494 | $63.98 | $415K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 492 | $64.75 | $32K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 18,545 | $63.02 | $1.17M | |
| Adam Taich - Officer | Open-market sale | Class A Common Stock | 17,166 | $63.02 | $1.08M | |
| Benjamin J. Hindson - Officer | Open-market sale | Class A Common Stock | 13,818 | $63.02 | $871K | |
| Shehnaaz Suliman - Director | Open-market sale | Class A Common Stock | 561 | $62.73 | $35K | |
| Shehnaaz Suliman - Director | Open-market sale | Class A Common Stock | 1,646 | $63.97 | $105K | |
| Serge Saxonov - Officer | Gift | Class A Common Stock | 4,000 | $0.00 | - | |
 Sarah A. Teichmann - Director | Open-market sale | Class A Common Stock | 5,278 | $57.29 | $302K | |
| Sarah A. Teichmann - Director | Open-market sale | Class A Common Stock | 2,273 | $57.15 | $130K | |
| John R. Stuelpnagel - Director | Open-market sale | Class A Common Stock | 17,000 | $57.58 | $979K | |
| John R. Stuelpnagel - Director | Open-market sale | Class A Common Stock | 3,000 | $58.73 | $176K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 8,527 | $33.29 | $284K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 9,991 | $34.28 | $343K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 9,821 | $35.32 | $347K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 1,661 | $36.16 | $60K | |
| Shehnaaz Suliman | Open-market sale | Class A Common Stock | 5,359 | $32.59 | $175K | |
| Shehnaaz Suliman | Open-market sale | Class A Common Stock | 364 | $33.27 | $12K | |
| Sarah A. Teichmann | Grant or award | Class A Common Stock | 8,829 | $0.00 | - | |
| Shehnaaz Suliman | Grant or award | Class A Common Stock | 8,829 | $0.00 | - | |
| John R. Stuelpnagel | Grant or award | Class A Common Stock | 8,829 | $0.00 | - | |
| Kimberly J. Popovits | Grant or award | Class A Common Stock | 8,829 | $0.00 | - | |
 Alan Mateo | Grant or award | Class A Common Stock | 8,829 | $0.00 | - | |
| Sridhar Kosaraju | Grant or award | Class A Common Stock | 8,829 | $0.00 | - | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 18,175 | $24.44 | $444K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 10,718 | $24.71 | $265K | |
| Benjamin J. Hindson - Officer | Open-market sale | Class A Common Stock | 11,595 | $24.44 | $283K | |
| Adam Taich - Officer | Open-market sale | Class A Common Stock | 15,098 | $24.44 | $369K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 5,000 | $24.56 | $123K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 10,000 | $19.13 | $191K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 5,000 | $19.52 | $98K | |
| Serge Saxonov - Officer | Gift | Class A Common Stock | 2,750 | $0.00 | - | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 14,292 | $22.67 | $324K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 1,860 | $23.18 | $43K | |
| Serge Saxonov - Officer | Grant or award | Class A Common Stock | 157,895 | $0.00 | - | |
| Benjamin J. Hindson - Officer | Grant or award | Class A Common Stock | 88,816 | $0.00 | - | |
| Adam Taich - Officer | Grant or award | Class A Common Stock | 106,579 | $0.00 | - | |
| Sarah A. Teichmann | Open-market sale | Class A Common Stock | 7,579 | $19.41 | $147K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 9,632 | $18.58 | $179K | |
| Adam Taich - Officer | Open-market sale | Class A Common Stock | 8,968 | $18.58 | $167K | |
| Benjamin J. Hindson - Officer | Open-market sale | Class A Common Stock | 7,826 | $18.58 | $145K | |
| Serge Saxonov - Officer | Option exercise | Class A Common Stock | 50,000 | $1.20 | $60K | |
| Serge Saxonov - Officer | Option exercise | Stock Option (right to buy) | 17,463 | $0.00 | - | |
| Serge Saxonov - Officer | Option exercise | Stock Option (right to buy) | 32,537 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Serge Saxonov | Director, CEO | 35,486 | $2.21M | View on EDGAR | |
| Saxonov Serge | Officer, Director | 17,948 | $1.17M | View on EDGAR | |
| Hindson Benjamin J. | Officer, Director | 13,373 | $871K | View on EDGAR |
10x Genomics, Inc. (TXG) had 16 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for TXG runs to 42 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TXG were filed in the last 90 days.
18 insider sales of TXG were filed in the last 90 days, totaling $6.74M.
This page tracks TXG Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TXG to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
